Physician profile
Anna Sullivan
NPI 1831212471
$1,161.92
in general payments reported to CMS, 2019-2025
12 companies · $261 in 2025
The $261 reported for 2025 was more than what a typical Acute Care (Nurse Practitioner) provider received nationally (typical 2025 total: $151).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $224 · 2022: $196 · 2023: $180 · 2024: $300 · 2025: $261.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $742.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $741.72 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals Lp | $221.74 | 2021-2023 | Farxiga |
| Medtronic, INC. | $212.77 | 2021-2022 | |
| Novartis Pharmaceuticals Corporation | $142.44 | 2023-2025 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $141.54 | 2023-2025 | Xifaxan |
| Verona Pharma, INC. | $125.00 | 2025 | Ohtuvayre |
| Pfizer INC. | $119.02 | 2023-2024 | |
| Abiomed | $66.10 | 2024 | Impella |
| Takeda Pharmaceuticals U.S.A., INC. | $49.81 | 2025 | Eohilia, Entyvio |
| Kiniksa Pharmaceuticals, Ltd. | $28.53 | 2023 | Arcalyst |
| Mallinckrodt Hospital Products INC. | $21.56 | 2025 | Terlivaz |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $18.39 | 2021 | |
| Abbott Laboratories | $15.02 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anna Sullivan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.